D. Sawamura, T. Yaguchi, I. Hashimoto, et tence of generalizad morphea with histological changes in lichen sclerosus et atrophicus and lichen planus. La morfea o esclerodermia localizada es una enfermedad inflamatoria distintiva que conduce a la esclerosis de la piel y los tejidos subyacentes. Incluye una. J. Vico, C. Méndez, G. Gomiz, A. González, S. Moreno. Article. Read the complete contents of this article. Already registered? E-mail or User. Password.
|Published (Last):||17 May 2009|
|PDF File Size:||11.63 Mb|
|ePub File Size:||3.18 Mb|
|Price:||Free* [*Free Regsitration Required]|
The data were entered in Excel version The type with the highest frequency of extra-cutaneous involvement was the Esclerodermia morfea in None of the patients developed esclerodermia morfea signs or serology compatible with systemic sclerosis during the follow-up.
It is surprising that in this series, the mixed forms and CDS esclerodermia morfea the longest times of latency between onset of symptoms and esclerodermia morfea, despite the multiplicity of lesions that characterize the generalized forms and the evident lesions on the face in CDS. Extra-cutaneous involvement according to the types and subtypes of scleroderma.
The following ezclerodermia were detected during follow-up: This form of scleroderma showed an important rate escleridermia esthetic alterations and growth disorders, as well as a longer time of latency between the onset of the symptoms and the diagnosis. Two patients with Hashimoto’s thyroiditis had positive antithyroid antibodies. An early diagnosis, a dynamic treatment and a esclerodermia morfea follow-up helps to prevent, and detect, complications arising from the disease.
Introduction Juvenile localized scleroderma essclerodermia a polymorphic disease.
Rodolfo: Esclerodermia Localizada, Morfea
El morrea muscular y la debilidad pueden tratarse con medicamentos antiinflamatorios como glucocorticoides prednisonainmunoglobulina intravenosa IVIg o medicamentos inmunodepresores. Both presented multifocal esthetic alterations extremities, trunk and face and growth disorders in esclerodermia morfea limbs mixed.
The selection criteria were all patients who completed at least one year of evolution of the disease and minimum 6 months of follow-up. Extra-cutaneous involvement according to the types and esclerodermia morfea of scleroderma.
esclerodermia morfea You can get your login by contacting Elsevier Spain in: If the mixed forms that include linear lesions are included, linear scleroderma esclerodermia morfea the most frequent. Objective To describe the clinical characteristics, morbidity and escletodermia in patients with juvenile localized scleroderma in different pediatric rheumatology clinics in Colombia. It diagnosed late in most of the esclerodermia morfea. One-third of the patients developed mixed forms of the disease.
Morphea in adults and children cohort II: Learning, early recognition of this pathology and a esclerodermia morfea referral to the rheumatologist should be promoted. Given the low prevalence of the disease, we included the universe of patients who met the inclusion criteria. Clin Dermatol, 33pp. The case of uveitis occurred in a patient with CDS.
Lina: Esclerodermia Morfea
Arthritis Rheum, 66esclerodermia morfea. The mean age at the onset of the disease was 7. Phenotypes of localized scleroderma according to the PRes classification. This type of scleroderma was associated with multiple esclerodermia morfea both esthetic and functional, especially when there were linear lesions associated with esclerodermua of another subtype, multiple lesions or facial involvement.
Received 26 SeptemberAccepted 07 October Resumen. It was present in 2 female patients. At the time of the follow-up there was no progression of the esclerodermia morfea to systemic sclerosis in any patient. Juvenile localized scleroderma esclerodermia morfea a polymorphic and unpredictable disease.
Paciente Historia: Nora: Esclerodermia Morfea
Please cite this article as: Chronic lesions of scleroderma in the lower limbs. Anticardiolipin Esclerodermia morfea and lupus anticoagulant were present, each in one patient. Morbidity was related, mostly, with esthetic esclerodermia morfea given the high frequency of dyschromia and to a lesser extent, alopecia and disfiguring effect Fig.
A descriptive, retrospective, and multicentre study was conducted on patients with juvenile localized scleroderma esclerdoermia a minimum of 1 year of disease onset, and 6 months of follow-up in 10 pediatric rheumatology clinics. Extra-cutaneous involvement was present in esclerodermia morfea a quarter of patients, which reflects that it is not a esclerodermia morfea limited to the skin.
Systemic scleroderma is characterized by involvement of internal organs and a worse prognosis.
Progresos de Obstetricia y Ginecología
In the case of lesions affecting the head, neurological and ocular complications may occur. Esclerodermia morfea associated morbidity esclerodermia morfea accompanied by a negative and permanent impact on the quality of life of the patients with a diagnosis of jLS.
Juvenile localized scleroderma is a polymorphic disease. There is no really effective and universal treatment so it is important to make a correct assessment of the extent and severity of the disease esclerodermia morfea deciding on a treatment approach.
With certain exceptions, the disorder does not have serious systemic repercussions, but it can cause considerable morbidity. Chronic changes in scleroderma characterized by areas of hyperpigmentation, hypopigmentation and cutaneous sclerosis.
The limitations of the study include the absence of information on a family history of autoimmunity and the treatment received by esclerodermia morfea patients, and the fact that esclerodermia morfea standardized follow-up tool was not used in the patients.